A detailed history of Virtus Fund Advisers, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 1,306 shares of HAE stock, worth $111,702. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,306
Previous 1,186 10.12%
Holding current value
$111,702
Previous $101,000 9.9%
% of portfolio
0.4%
Previous 0.63%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $8,548 - $10,242
120 Added 10.12%
1,306 $111,000
Q3 2023

Nov 08, 2023

BUY
$82.56 - $93.49 $12,796 - $14,490
155 Added 15.03%
1,186 $106,000
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $76,139 - $88,810
1,031 New
1,031 $81,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.